Corcept Therapeutics
CORT
#2078
Rank
โ‚น815.08 B
Marketcap
โ‚น7,735
Share price
1.71%
Change (1 day)
53.73%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น37.88 Billion

According to Corcept Therapeutics 's latest financial reports the company has โ‚น37.88 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น32.88 B7.28%
2023-12-31โ‚น30.65 B-14.18%
2022-12-31โ‚น35.72 B114.69%
2021-12-31โ‚น16.63 B-48.38%
2020-12-31โ‚น32.22 B63.78%
2019-12-31โ‚น19.67 B36.12%
2018-12-31โ‚น14.45 B155.14%
2017-12-31โ‚น5.66 B61.8%
2016-12-31โ‚น3.50 B30.33%
2015-12-31โ‚น2.68 B74.85%
2014-12-31โ‚น1.53 B-54.67%
2013-12-31โ‚น3.39 B-33.44%
2012-12-31โ‚น5.09 B142.94%
2011-12-31โ‚น2.09 B90.38%
2010-12-31โ‚น1.10 B-0.55%
2009-12-31โ‚น1.10 B25.84%
2008-12-31โ‚น0.88 B29.12%
2007-12-31โ‚น0.68 B62.73%
2006-12-31โ‚น0.41 B-68%
2005-12-31โ‚น1.30 B-19.21%
2004-12-31โ‚น1.61 B207.29%
2003-12-31โ‚น0.52 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.667 T 4,301.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.482 T 3,813.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น876.17 B 2,212.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น890.59 B 2,250.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.346 T 3,453.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.636 T 4,219.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น8.30 B-78.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚น23.36 B-38.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น132.76 B 250.46%๐Ÿ‡บ๐Ÿ‡ธ USA